Jazz Pharmaceuticals plc (JAZZ)
USD 120.05
(2.45%)
USD 120.05
(2.45%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 3.25 Billion USD | -18.24% |
| 2022 | 2.6 Billion USD | 4.97% |
| 2021 | 2.48 Billion USD | 71.35% |
| 2020 | 1.44 Billion USD | 4.15% |
| 2019 | 1.39 Billion USD | 25.17% |
| 2018 | 1.11 Billion USD | 24.25% |
| 2017 | 894.66 Million USD | 16.62% |
| 2016 | 767.18 Million USD | 12.4% |
| 2015 | 682.53 Million USD | 10.46% |
| 2014 | 617.87 Million USD | 43.7% |
| 2013 | 429.96 Million USD | 38.83% |
| 2012 | 309.71 Million USD | 137.32% |
| 2011 | 130.5 Million USD | 27.4% |
| 2010 | 102.43 Million USD | -0.44% |
| 2009 | 102.88 Million USD | -47.02% |
| 2008 | 194.19 Million USD | -0.51% |
| 2007 | 195.17 Million USD | 68.34% |
| 2006 | 115.94 Million USD | 56.06% |
| 2005 | 74.29 Million USD | 399.52% |
| 2004 | -24.8 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 574.55 Million USD | 4.29% |
| 2024 Q2 | 559.25 Million USD | -2.66% |
| 2023 Q2 | 702.14 Million USD | 10.21% |
| 2023 FY | 2.13 Billion USD | -18.24% |
| 2023 Q4 | 550.91 Million USD | -21.03% |
| 2023 Q3 | 697.59 Million USD | -0.65% |
| 2023 Q1 | 637.11 Million USD | -8.08% |
| 2022 Q2 | 653.97 Million USD | 7.05% |
| 2022 Q1 | 610.88 Million USD | -14.1% |
| 2022 FY | 2.6 Billion USD | 4.97% |
| 2022 Q4 | 693.14 Million USD | 6.87% |
| 2022 Q3 | 648.58 Million USD | -0.83% |
| 2021 Q3 | 664.52 Million USD | -5.37% |
| 2021 Q1 | 405.27 Million USD | -0.17% |
| 2021 Q2 | 702.2 Million USD | 73.27% |
| 2021 Q4 | 711.19 Million USD | 7.02% |
| 2021 FY | 2.48 Billion USD | 71.35% |
| 2020 Q3 | 352.58 Million USD | 5.79% |
| 2020 FY | 1.44 Billion USD | 4.15% |
| 2020 Q4 | 405.94 Million USD | 15.13% |
| 2020 Q1 | 357.35 Million USD | -26.34% |
| 2020 Q2 | 333.3 Million USD | -6.73% |
| 2019 FY | 1.39 Billion USD | 25.17% |
| 2019 Q2 | 299.97 Million USD | 5.28% |
| 2019 Q3 | 321.42 Million USD | 7.15% |
| 2019 Q4 | 485.14 Million USD | 50.94% |
| 2019 Q1 | 284.93 Million USD | 7.5% |
| 2018 FY | 1.11 Billion USD | 24.25% |
| 2018 Q4 | 265.06 Million USD | 4.35% |
| 2018 Q3 | 254.02 Million USD | -5.8% |
| 2018 Q2 | 269.67 Million USD | -16.48% |
| 2018 Q1 | 322.88 Million USD | 23.26% |
| 2017 Q1 | 214.84 Million USD | 8.81% |
| 2017 FY | 894.66 Million USD | 16.62% |
| 2017 Q4 | 261.94 Million USD | 19.5% |
| 2017 Q3 | 219.19 Million USD | 10.33% |
| 2017 Q2 | 198.67 Million USD | -7.53% |
| 2016 FY | 767.18 Million USD | 12.4% |
| 2016 Q1 | 182.65 Million USD | 2.22% |
| 2016 Q4 | 197.46 Million USD | -0.58% |
| 2016 Q3 | 198.61 Million USD | 5.4% |
| 2016 Q2 | 188.44 Million USD | 3.17% |
| 2015 Q3 | 180.95 Million USD | 14.07% |
| 2015 FY | 682.53 Million USD | 10.46% |
| 2015 Q1 | 164.24 Million USD | 1.24% |
| 2015 Q2 | 158.63 Million USD | -3.42% |
| 2015 Q4 | 178.7 Million USD | -1.25% |
| 2014 Q2 | 153.44 Million USD | -1.42% |
| 2014 FY | 617.87 Million USD | 43.7% |
| 2014 Q1 | 155.65 Million USD | 34.61% |
| 2014 Q4 | 162.23 Million USD | 10.7% |
| 2014 Q3 | 146.55 Million USD | -4.49% |
| 2013 Q4 | 115.63 Million USD | 7.72% |
| 2013 FY | 429.96 Million USD | 38.83% |
| 2013 Q2 | 106.15 Million USD | 5.28% |
| 2013 Q1 | 100.83 Million USD | 11.34% |
| 2013 Q3 | 107.34 Million USD | 1.12% |
| 2012 Q2 | 78.71 Million USD | 22.09% |
| 2012 FY | 309.71 Million USD | 137.32% |
| 2012 Q1 | 64.47 Million USD | 53.47% |
| 2012 Q4 | 90.56 Million USD | 3.4% |
| 2012 Q3 | 87.58 Million USD | 11.28% |
| 2011 Q1 | 25.46 Million USD | 10.49% |
| 2011 Q2 | 27.33 Million USD | 7.34% |
| 2011 Q3 | 35.68 Million USD | 30.54% |
| 2011 Q4 | 42.01 Million USD | 17.71% |
| 2011 FY | 130.5 Million USD | 27.4% |
| 2010 FY | 102.43 Million USD | -0.44% |
| 2010 Q2 | 27.1 Million USD | 8.14% |
| 2010 Q1 | 25.06 Million USD | 4.03% |
| 2010 Q4 | 23.05 Million USD | -15.32% |
| 2010 Q3 | 27.21 Million USD | 0.43% |
| 2009 Q3 | 24.76 Million USD | -7.16% |
| 2009 Q4 | 24.09 Million USD | -2.71% |
| 2009 FY | 102.88 Million USD | -47.02% |
| 2009 Q2 | 26.67 Million USD | -2.5% |
| 2009 Q1 | 27.35 Million USD | -28.47% |
| 2008 Q3 | 39.96 Million USD | -33.21% |
| 2008 Q4 | 38.24 Million USD | -4.3% |
| 2008 Q1 | 56.14 Million USD | -20.85% |
| 2008 Q2 | 59.83 Million USD | 6.58% |
| 2008 FY | 194.19 Million USD | -0.51% |
| 2007 Q1 | 31.56 Million USD | 125.68% |
| 2007 Q4 | 70.93 Million USD | 90.01% |
| 2007 Q2 | 55.33 Million USD | 75.3% |
| 2007 Q3 | 37.33 Million USD | -32.53% |
| 2007 FY | 195.17 Million USD | 68.34% |
| 2006 Q4 | -122.9 Million USD | 0.0% |
| 2006 FY | 115.94 Million USD | 56.06% |
| 2006 Q1 | - USD | 100.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2005 Q4 | -78.58 Million USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 FY | 74.29 Million USD | 399.52% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2004 FY | -24.8 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Absci Corporation | 73.66 Million USD | -4319.439% |
| Adaptive Biotechnologies Corporation | 321.75 Million USD | -911.824% |
| Alnylam Pharmaceuticals, Inc. | 1.8 Billion USD | -80.862% |
| Alzamend Neuro, Inc. | 9.93 Million USD | -32660.518% |
| Apollomics, Inc. | 54.14 Million USD | -5913.343% |
| 180 Life Sciences Corp. | 13.47 Million USD | -24055.993% |
| Atossa Therapeutics, Inc. | 31.37 Million USD | -10275.829% |
| Bicycle Therapeutics plc | 216.92 Million USD | -1400.827% |
| Barinthus Biotherapeutics plc | 84.71 Million USD | -3742.986% |
| BioXcel Therapeutics, Inc. | 171.9 Million USD | -1793.884% |
| CASI Pharmaceuticals, Inc. | 47 Million USD | -6825.975% |
| Chimerix, Inc. | 93.38 Million USD | -3386.089% |
| CRISPR Therapeutics AG | 463.49 Million USD | -602.409% |
| Contineum Therapeutics, Inc. Class A Common Stock | 33.72 Million USD | -9552.585% |
| EyePoint Pharmaceuticals, Inc. | 116.45 Million USD | -2695.655% |
| Fortress Biotech, Inc. | 200.19 Million USD | -1526.226% |
| Fortress Biotech, Inc. | 200.19 Million USD | -1526.226% |
| Gritstone bio, Inc. | 148.37 Million USD | -2094.201% |
| Allakos Inc. | 196.05 Million USD | -1560.558% |
| Boundless Bio, Inc. Common Stock | 54.79 Million USD | -5841.353% |
| Cara Therapeutics, Inc. | 142.46 Million USD | -2185.242% |
| Cytokinetics, Incorporated | 173.61 Million USD | -1775.23% |
| enGene Holdings Inc. Common Stock | 25.88 Million USD | -12477.261% |
| Innoviva, Inc. | 132.15 Million USD | -2363.508% |
| Hoth Therapeutics, Inc. | 7.69 Million USD | -42223.473% |
| NLS Pharmaceutics AG | 11.8 Million USD | -27473.53% |
| RAPT Therapeutics, Inc. | 127.06 Million USD | -2462.233% |
| Salarius Pharmaceuticals, Inc. | 12.89 Thousand USD | -25249039.134% |
| Terns Pharmaceuticals, Inc. | 102.55 Million USD | -3074.422% |
| Vigil Neuroscience, Inc. | 88.86 Million USD | -3563.52% |
| ImmuCell Corporation | 9.61 Million USD | -33751.528% |
| IDEAYA Biosciences, Inc. | 157.81 Million USD | -1962.95% |
| Incyte Corporation | 1.19 Billion USD | -173.468% |
| Inovio Pharmaceuticals, Inc. | 132.55 Million USD | -2356.053% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -48283.93% |
| Mustang Bio, Inc. | 48.5 Million USD | -6612.488% |
| MiMedx Group, Inc. | 229.72 Million USD | -1317.171% |
| MEI Pharma, Inc. | 34.78 Million USD | -9259.276% |
| MacroGenics, Inc. | 217.21 Million USD | -1398.803% |
| Monopar Therapeutics Inc. | 8.83 Million USD | -36764.878% |
| Mereo BioPharma Group plc | 35.84 Million USD | -8983.265% |
| Marker Therapeutics, Inc. | 17.89 Million USD | -18095.456% |
| Marinus Pharmaceuticals, Inc. | 160.54 Million USD | -1927.921% |
| Maravai LifeSciences Holdings, Inc. | 171.85 Million USD | -1794.457% |
| Minerva Neurosciences, Inc. | 23.08 Million USD | -14000.573% |
| NeuroBo Pharmaceuticals, Inc. | 15.88 Million USD | -20393.667% |
| NeuroSense Therapeutics Ltd. | 10.28 Million USD | -31554.098% |
| NextCure, Inc. | 67.63 Million USD | -4713.377% |
| Orchestra BioMed Holdings, Inc. | 54.08 Million USD | -5920.015% |
| Ocuphire Pharma, Inc. | 29.6 Million USD | -10896.501% |
| Onconetix, Inc. | 34.9 Million USD | -9226.45% |
| Oncternal Therapeutics, Inc. | 12.74 Million USD | -25442.319% |
| Opthea Limited | 191.96 Million USD | -1595.925% |
| Ovid Therapeutics Inc. | 59.67 Million USD | -5355.759% |
| Psyence Biomedical Ltd. | 2.75 Million USD | -118218.133% |
| PDS Biotechnology Corporation | 43.04 Million USD | -7463.262% |
| Precigen, Inc. | 84.18 Million USD | -3767.41% |
| Pieris Pharmaceuticals, Inc. | 72.56 Million USD | -4386.432% |
| Prime Medicine, Inc. | 186.63 Million USD | -1644.343% |
| PureTech Health plc | 144.59 Million USD | -2151.516% |
| Rocket Pharmaceuticals, Inc. | 259.65 Million USD | -1153.807% |
| Regeneron Pharmaceuticals, Inc. | 2.81 Billion USD | -15.64% |
| Replimune Group, Inc. | 234.77 Million USD | -1286.711% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -37508.298% |
| Rigel Pharmaceuticals, Inc. | 130.26 Million USD | -2399.27% |
| TransCode Therapeutics, Inc. | 19.41 Million USD | -16665.565% |
| Revolution Medicines, Inc. Warrant | 498.76 Million USD | -552.737% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -13293.987% |
| Sesen Bio, Inc. | 78.38 Million USD | -4053.588% |
| Sangamo Therapeutics, Inc. | 228.68 Million USD | -1323.659% |
| Solid Biosciences Inc. | 104.31 Million USD | -3020.955% |
| Syndax Pharmaceuticals, Inc. | 229.95 Million USD | -1315.772% |
| SciSparc Ltd. | 9.01 Million USD | -36029.442% |
| Sutro Biopharma, Inc. | 243 Million USD | -1239.713% |
| TG Therapeutics, Inc. | 198.47 Million USD | -1540.319% |
| Tonix Pharmaceuticals Holding Corp. | 121.4 Million USD | -2581.578% |
| Titan Pharmaceuticals, Inc. | 7.46 Million USD | -43535.223% |
| Travere Therapeutics, Inc. | 472 Million USD | -589.748% |
| UroGen Pharma Ltd. | 138.88 Million USD | -2244.064% |
| Verrica Pharmaceuticals Inc. | 70.59 Million USD | -4511.757% |
| XOMA Corporation | 46.46 Million USD | -6906.917% |
| Zentalis Pharmaceuticals, Inc. | 252.55 Million USD | -1189.091% |
| AbCellera Biologics Inc. | 275.23 Million USD | -1082.865% |
| Longboard Pharmaceuticals, Inc. | 56.75 Million USD | -5635.873% |
| Cassava Sciences, Inc. | 105.95 Million USD | -2972.59% |
| Corbus Pharmaceuticals Holdings, Inc. | 13.9 Million USD | -23305.521% |
| Precision BioSciences, Inc. | 92.46 Million USD | -3421.002% |
| Dyadic International, Inc. | 9.15 Million USD | -35470.11% |
| Intensity Therapeutics, Inc. | 8.31 Million USD | -39034.8% |
| Eton Pharmaceuticals, Inc. | 22.25 Million USD | -14530.045% |
| VYNE Therapeutics Inc. | 29.68 Million USD | -10868.344% |
| Tenaya Therapeutics, Inc. | 131.19 Million USD | -2381.553% |
| IGM Biosciences, Inc. | 265.59 Million USD | -1125.804% |
| X4 Pharmaceuticals, Inc. | 107.52 Million USD | -2927.868% |
| Acelyrin, Inc. | 422.06 Million USD | -671.358% |
| Abeona Therapeutics Inc. | 17.93 Million USD | -18048.302% |
| Ligand Pharmaceuticals Incorporated | 84.32 Million USD | -3760.897% |
| Inhibikase Therapeutics, Inc. | 6.73 Million USD | -48260.83% |
| Arcturus Therapeutics Holdings Inc. | 245 Million USD | -1228.804% |
| Syros Pharmaceuticals, Inc. | 30.77 Million USD | -10480.17% |
| Senti Biosciences, Inc. | 94.7 Million USD | -3337.647% |
| Mesoblast Limited | 5.9 Million USD | -55061.369% |
| Kymera Therapeutics, Inc. | 244.12 Million USD | -1233.605% |
| ChromaDex Corporation | 56.37 Million USD | -5674.533% |
| BriaCell Therapeutics Corp. | 33.33 Million USD | -9667.827% |
| Akebia Therapeutics, Inc. | 201.11 Million USD | -1518.787% |
| Dermata Therapeutics, Inc. | 8.04 Million USD | -40383.239% |
| Seer, Inc. | 110.49 Million USD | -2846.533% |
| Xeris Biopharma Holdings, Inc. | 168.43 Million USD | -1832.855% |
| Novavax, Inc. | 779.12 Million USD | -317.856% |
| Virpax Pharmaceuticals, Inc. | 15.68 Million USD | -20649.955% |
| Fate Therapeutics, Inc. | 254.04 Million USD | -1181.52% |
| Checkpoint Therapeutics, Inc. | 52.25 Million USD | -6130.74% |
| Lyell Immunopharma, Inc. | 247.13 Million USD | -1217.33% |
| Celcuity Inc. | 66.23 Million USD | -4815.609% |
| ContextLogic Inc. | 387 Million USD | -741.247% |
| Phathom Pharmaceuticals, Inc. | 167.82 Million USD | -1839.869% |
| HOOKIPA Pharma Inc. | 32.74 Million USD | -9842.051% |
| Amarin Corporation plc | 272.35 Million USD | -1095.352% |
| AnaptysBio, Inc. | 181.56 Million USD | -1693.06% |
| Aptevo Therapeutics Inc. | 28.87 Million USD | -11173.717% |
| Aptorum Group Limited | 10.56 Thousand USD | -30812165.758% |
| Cartesian Therapeutics, Inc. | 110.86 Million USD | -2836.513% |
| Arrowhead Pharmaceuticals, Inc. | 445.73 Million USD | -630.391% |
| Ardelyx, Inc. | 169.93 Million USD | -1815.783% |
| Celularity Inc. | 215.05 Million USD | -1413.835% |
| Omeros Corporation | 94.75 Million USD | -3335.979% |
| Humacyte, Inc. | 23.49 Million USD | -13755.488% |
| Immunocore Holdings plc | 308.04 Million USD | -956.884% |
| IO Biotech, Inc. | 91.44 Million USD | -3460.277% |
| GT Biopharma, Inc. | 13.57 Million USD | -23880.731% |
| Cabaletta Bio, Inc. | 74.66 Million USD | -4260.6% |
| Summit Therapeutics Inc. | 87.68 Million USD | -3612.821% |
| Alaunos Therapeutics, Inc. | 29.46 Million USD | -10947.623% |
| Pulmatrix, Inc. | 22.03 Million USD | -14672.774% |
| Intellia Therapeutics, Inc. | 551.56 Million USD | -490.251% |
| Evogene Ltd. | 27.79 Million USD | -11615.092% |
| CorMedix Inc. | 48.95 Million USD | -6549.859% |
| BioLineRx Ltd. | 50.8 Million USD | -6308.456% |
| VistaGen Therapeutics, Inc. | 34.08 Million USD | -9451.486% |
| Sagimet Biosciences Inc. | 32.74 Million USD | -9843.873% |
| PTC Therapeutics, Inc. | 1.31 Billion USD | -148.173% |
| scPharmaceuticals Inc. | 65.17 Million USD | -4894.974% |
| Fulcrum Therapeutics, Inc. | 113.46 Million USD | -2769.175% |
| Corcept Therapeutics Incorporated | 368.61 Million USD | -783.212% |
| NLS Pharmaceutics AG | 11.8 Million USD | -27473.53% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -13293.987% |
| Akero Therapeutics, Inc. | 172.87 Million USD | -1783.279% |
| Eliem Therapeutics, Inc. | 37.4 Million USD | -8603.015% |
| Lisata Therapeutics, Inc. | 25.7 Million USD | -12563.856% |
| Stoke Therapeutics, Inc. | 123.55 Million USD | -2535.002% |
| Reneo Pharmaceuticals, Inc. | 83.05 Million USD | -3819.935% |
| Outlook Therapeutics, Inc. | 53.12 Million USD | -6028.074% |
| ProMIS Neurosciences, Inc. | 8.45 Million USD | -38415.624% |
| Daré Bioscience, Inc. | 33.6 Million USD | -9586.647% |
| bluebird bio, Inc. | 240.23 Million USD | -1255.2% |
| BioMarin Pharmaceutical Inc. | 1.74 Billion USD | -86.432% |
| DBV Technologies S.A. | 92.16 Million USD | -3432.578% |
| Avidity Biosciences, Inc. | 245.15 Million USD | -1227.97% |
| Galecto, Inc. | 35.62 Million USD | -9038.081% |
| Sensei Biotherapeutics, Inc. | 37.06 Million USD | -8683.79% |
| Spruce Biosciences, Inc. | 62.08 Million USD | -5144.071% |
| Inhibrx Biosciences, Inc. | 219.83 Million USD | -1380.973% |
| GlycoMimetics, Inc. | 39.28 Million USD | -8187.132% |
| Arcutis Biotherapeutics, Inc. | 295.72 Million USD | -1000.914% |
| ADMA Biologics, Inc. | 66.58 Million USD | -4789.352% |
| Clene Inc. | 41.07 Million USD | -7826.433% |
| Recursion Pharmaceuticals, Inc. | 352.04 Million USD | -824.767% |
| Aptose Biosciences Inc. | 52.35 Million USD | -6118.244% |
| ZyVersa Therapeutics, Inc. | 14.41 Million USD | -22492.224% |
| Soligenix, Inc. | 7.79 Million USD | -41664.197% |
| Century Therapeutics, Inc. | 56.07 Million USD | -5706.253% |
| Kura Oncology, Inc. | 165.8 Million USD | -1863.538% |
| Surrozen, Inc. | 18.55 Million USD | -17450.534% |
| TScan Therapeutics, Inc. | 114.5 Million USD | -2743.166% |
| Ocean Biomedical, Inc. | 2.48 Million USD | -131088.461% |
| CytomX Therapeutics, Inc. | 107.69 Million USD | -2922.92% |
| Autolus Therapeutics plc | 196.72 Million USD | -1554.903% |
| Mineralys Therapeutics, Inc. | 84.65 Million USD | -3745.664% |
| Eterna Therapeutics Inc. | 19.38 Million USD | -16696.285% |
| Caribou Biosciences, Inc. | 150.53 Million USD | -2062.688% |
| GRI Bio, Inc. | 11.33 Million USD | -28634.545% |
| Xenetic Biosciences, Inc. | 7.05 Million USD | -46041.751% |
| Janux Therapeutics, Inc. | 81.06 Million USD | -3916.215% |
| INmune Bio, Inc. | 29.89 Million USD | -10789.831% |
| Heron Therapeutics, Inc. | 172.55 Million USD | -1786.728% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -7975.604% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -20273.931% |
| Tenax Therapeutics, Inc. | 8.23 Million USD | -39439.074% |
| Jaguar Health, Inc. | 42.01 Million USD | -7648.718% |
| Entero Therapeutics, Inc. | 15.74 Million USD | -20581.721% |
| Milestone Pharmaceuticals Inc. | 62.09 Million USD | -5142.72% |
| Clearside Biomedical, Inc. | 32.71 Million USD | -9851.472% |
| Atara Biotherapeutics, Inc. | 275.69 Million USD | -1080.887% |
| Coherus BioSciences, Inc. | 301.45 Million USD | -979.984% |
| Verastem, Inc. | 92.08 Million USD | -3435.494% |
| Pliant Therapeutics, Inc. | 185.72 Million USD | -1652.927% |
| Histogen Inc. | 14.27 Million USD | -22711.267% |
| Aprea Therapeutics, Inc. | 16.04 Million USD | -20186.61% |
| ACADIA Pharmaceuticals Inc. | 754.08 Million USD | -331.732% |
| Surrozen, Inc. | 18.55 Million USD | -17450.534% |
| Organovo Holdings, Inc. | 14.91 Million USD | -21727.851% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -63858.213% |
| Cadrenal Therapeutics, Inc. Common Stock | 7.63 Million USD | -42552.836% |
| Centessa Pharmaceuticals plc | 178.13 Million USD | -1727.606% |
| Hepion Pharmaceuticals, Inc. | 48.44 Million USD | -6619.838% |
| BioRestorative Therapies, Inc. | 15.36 Million USD | -21086.401% |
| Kronos Bio, Inc. | 128.11 Million USD | -2441.114% |
| Turnstone Biologics Corp. | 78.33 Million USD | -4055.868% |
| Synaptogenix, Inc. | 8.31 Million USD | -39059.023% |
| Tiziana Life Sciences Ltd | 14.58 Million USD | -22220.197% |
| Entrada Therapeutics, Inc. | 132.17 Million USD | -2363.116% |
| Aurinia Pharmaceuticals Inc. | 253.05 Million USD | -1186.523% |
| Exelixis, Inc. | 1.58 Billion USD | -105.172% |
| Nurix Therapeutics, Inc. | 232.05 Million USD | -1302.984% |
| Apellis Pharmaceuticals, Inc. | 855.2 Million USD | -280.685% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -4627.82% |
| ESSA Pharma Inc. | 32.13 Million USD | -10031.367% |
| TNF Pharmaceuticals, Inc. | 16.36 Million USD | -19799.637% |
| Avid Bioservices, Inc. | 25.99 Million USD | -12423.557% |
| Insmed Incorporated | 949.26 Million USD | -242.964% |
| MediWound Ltd. | 18.86 Million USD | -17154.738% |
| OmniAb, Inc. | 83.89 Million USD | -3780.594% |
| Alector, Inc. | 248.8 Million USD | -1208.52% |
| Seres Therapeutics, Inc. | 234.3 Million USD | -1289.463% |
| Zai Lab Limited | 547.47 Million USD | -494.661% |
| AlloVir, Inc. | 180.93 Million USD | -1699.353% |
| Revance Therapeutics, Inc. | 398.65 Million USD | -716.654% |
| ORIC Pharmaceuticals, Inc. | 110.78 Million USD | -2838.819% |
| Aura Biosciences, Inc. | 84.99 Million USD | -3730.551% |
| Immunic, Inc. | 99.22 Million USD | -3181.118% |
| Tarsus Pharmaceuticals, Inc. | 159.01 Million USD | -1947.408% |
| Veracyte, Inc. | 357.93 Million USD | -809.562% |
| InMed Pharmaceuticals Inc. | 9.01 Billion USD | 63.89% |
| FibroGen, Inc. | 398.11 Million USD | -717.764% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -22810.795% |
| Catalyst Pharmaceuticals, Inc. | 259.42 Million USD | -1154.938% |
| Adial Pharmaceuticals, Inc. | 6.88 Million USD | -47165.52% |
| Sonnet BioTherapeutics Holdings, Inc. | 7.12 Million USD | -45588.275% |
| Cyclacel Pharmaceuticals, Inc. | 25.87 Million USD | -12483.094% |
| Amylyx Pharmaceuticals, Inc. | 316.54 Million USD | -928.493% |
| Fortrea Holdings Inc. | 457.3 Million USD | -611.923% |
| KalVista Pharmaceuticals, Inc. | 54.27 Million USD | -5898.054% |
| XBiotech Inc. | 37.51 Million USD | -8579.35% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -4627.82% |
| Keros Therapeutics, Inc. | 169.27 Million USD | -1823.252% |
| SELLAS Life Sciences Group, Inc. | 37.86 Million USD | -8497.069% |
| Lyra Therapeutics, Inc. | 20.64 Million USD | -15666.497% |
| Foghorn Therapeutics Inc. | 142.06 Million USD | -2191.708% |
| Agenus Inc. | 78.18 Million USD | -4064.107% |
| Y-mAbs Therapeutics, Inc. | 99.07 Million USD | -3186.02% |
| Theravance Biopharma, Inc. | 110.71 Million USD | -2840.518% |
| Ultragenyx Pharmaceutical Inc. | 958.24 Million USD | -239.748% |
| Metagenomi, Inc. Common Stock | 28.84 Million USD | -11186.615% |
| BioCryst Pharmaceuticals, Inc. | 430.64 Million USD | -655.997% |
| Gain Therapeutics, Inc. | 22.3 Million USD | -14493.77% |
| C4 Therapeutics, Inc. | 159.78 Million USD | -1937.477% |
| Creative Medical Technology Holdings, Inc. | 5.53 Million USD | -58761.953% |
| Chemomab Therapeutics Ltd. | 25.45 Million USD | -12687.714% |
| Lantern Pharma Inc. | 17.87 Million USD | -18110.663% |
| Eledon Pharmaceuticals, Inc. | 43 Million USD | -7471.219% |
| Ainos, Inc. | 12.95 Million USD | -25034.785% |
| Pluri Inc. | 22.48 Million USD | -14382.313% |
| Prothena Corporation plc | 282.4 Million USD | -1052.817% |
| Adaptimmune Therapeutics plc | 200.02 Million USD | -1527.633% |
| Rallybio Corporation | 78.93 Million USD | -4024.593% |
| Kodiak Sciences Inc. | 277.32 Million USD | -1073.955% |
| Cue Biopharma, Inc. | 19.54 Million USD | -16559.625% |
| MeiraGTx Holdings plc | 151.07 Million USD | -2054.929% |
| Annexon, Inc. | 143.72 Million USD | -2165.207% |
| Assembly Biosciences, Inc. | 22.9 Million USD | -14111.114% |
| Moderna, Inc. | 6.39 Billion USD | 49.083% |
| Cocrystal Pharma, Inc. | 3.39 Million USD | -95936.106% |
| Cidara Therapeutics, Inc. | 86.86 Million USD | -3647.912% |
| Blueprint Medicines Corporation | 722.86 Million USD | -350.38% |
| Immix Biopharma, Inc. | 16.14 Million USD | -20069.762% |
| CalciMedica, Inc. | 21.81 Million USD | -14822.418% |
| Monte Rosa Therapeutics, Inc. | 143.31 Million USD | -2171.72% |
| Scholar Rock Holding Corporation | 171.29 Million USD | -1800.595% |
| Wave Life Sciences Ltd. | 181.3 Million USD | -1695.701% |
| Sana Biotechnology, Inc. | 294.94 Million USD | -1003.826% |
| Elicio Therapeutics, Inc. | 34.57 Million USD | -9316.121% |
| Adlai Nortye Ltd. American Depositary Shares | 72.55 Million USD | -4387.359% |
| Nutriband Inc. | 5.73 Million USD | -56677.231% |
| Protara Therapeutics, Inc. | 43.61 Million USD | -7364.802% |
| Vor Biopharma Inc. | 126.03 Million USD | -2483.091% |
| Roivant Sciences Ltd. | 1.18 Billion USD | -173.771% |
| Alkermes plc | 996.24 Million USD | -226.789% |
| ProKidney Corp. | 151.52 Million USD | -2048.615% |
| Applied Therapeutics, Inc. | 74.17 Million USD | -4289.112% |
| Arcellx, Inc. | 200.19 Million USD | -1526.194% |
| BridgeBio Pharma, Inc. | 614.22 Million USD | -430.036% |
| Tango Therapeutics, Inc. | 150.7 Million USD | -2060.334% |
| Galectin Therapeutics Inc. | 38.07 Million USD | -8451.229% |
| Atai Life Sciences N.V. | 125.78 Million USD | -2488.245% |
| Renovaro Biosciences Inc. | 81.63 Million USD | -3887.815% |
| Aerovate Therapeutics, Inc. | 81.4 Million USD | -3899.096% |
| MediciNova, Inc. | 10.9 Million USD | -29767.384% |
| Praxis Precision Medicines, Inc. | 128.82 Million USD | -2427.266% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -44746.246% |
| GeoVax Labs, Inc. | 6.02 Million USD | -53960.619% |
| Axsome Therapeutics, Inc. | 476.36 Million USD | -583.438% |
| Biomea Fusion, Inc. | 126.13 Million USD | -2481.063% |
| RenovoRx, Inc. | 11.39 Million USD | -28468.129% |
| Cullinan Oncology, Inc. | 191.08 Million USD | -1603.721% |
| Geron Corporation | 70.44 Million USD | -4521.774% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -11703.437% |
| 4D Molecular Therapeutics, Inc. | 133.59 Million USD | -2337.027% |
| Dyne Therapeutics, Inc. | 242.16 Million USD | -1244.399% |
| Kiniksa Pharmaceuticals, Ltd. | 262.04 Million USD | -1142.377% |
| Royalty Pharma plc | 862.4 Million USD | -277.506% |
| Ventyx Biosciences, Inc. | 207.99 Million USD | -1465.249% |
| Imunon, Inc. | 20.31 Million USD | -15929.325% |
| BioAtla, Inc. | 129.68 Million USD | -2410.37% |
| Allogene Therapeutics, Inc. | 84.91 Million USD | -3733.844% |
| Larimar Therapeutics, Inc. | 41.75 Million USD | -7696.408% |
| Mersana Therapeutics, Inc. | 207.81 Million USD | -1466.62% |
| Structure Therapeutics Inc. | 102.77 Million USD | -3067.72% |
| 89bio, Inc. | 151.2 Million USD | -2053.134% |
| Kezar Life Sciences, Inc. | 111.17 Million USD | -2828.483% |
| aTyr Pharma, Inc. | 12.97 Million USD | -24983.781% |
| Aligos Therapeutics, Inc. | 103.65 Million USD | -3040.796% |
| Viridian Therapeutics, Inc. | 254.76 Million USD | -1177.898% |
| EyeGate Pharmaceuticals, Inc. | 8.22 Million USD | -39482.95% |
| Akari Therapeutics, Plc | 16.8 Million USD | -19271.796% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -143069.171% |
| Halozyme Therapeutics, Inc. | 299.31 Million USD | -987.681% |
| Lexicon Pharmaceuticals, Inc. | 172.86 Million USD | -1783.29% |
| Liquidia Corporation | 87.98 Million USD | -3600.245% |
| Entera Bio Ltd. | 8.86 Million USD | -36645.192% |
| GH Research PLC | 41.22 Million USD | -7797.783% |
| Vericel Corporation | 142.04 Million USD | -2192.047% |
| Arbutus Biopharma Corporation | 22.54 Million USD | -14341.199% |
| Xencor, Inc. | 306.97 Million USD | -960.543% |
| 60 Degrees Pharmaceuticals, Inc. | 4.93 Million USD | -65888.731% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -20273.931% |
| Coeptis Therapeutics Holdings, Inc. | 20.48 Million USD | -15788.93% |
| Vaxcyte, Inc. | 468.04 Million USD | -595.585% |
| Xenon Pharmaceuticals Inc. | 46.54 Million USD | -6895.024% |
| Vanda Pharmaceuticals Inc. | 191.79 Million USD | -1597.441% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -48283.93% |
| Portage Biotech Inc. | 18.19 Million USD | -17789.027% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -44746.246% |
| Olema Pharmaceuticals, Inc. | 104.96 Million USD | -3001.746% |
| OncoCyte Corporation | 25.63 Million USD | -12598.927% |
| Qualigen Therapeutics, Inc. | 6.09 Million USD | -53309.349% |
| Processa Pharmaceuticals, Inc. | 11.45 Million USD | -28315.874% |
| Purple Biotech Ltd. | -22.46 Million USD | 14590.693% |
| Tempest Therapeutics, Inc. | 29.15 Million USD | -11065.84% |
| Sol-Gel Technologies Ltd. | 30.85 Million USD | -10449.998% |
| Rhythm Pharmaceuticals, Inc. | 252.48 Million USD | -1189.443% |
| CollPlant Biotechnologies Ltd. | 16.48 Million USD | -19655.0% |
| Moleculin Biotech, Inc. | 29.63 Million USD | -10887.223% |
| United Therapeutics Corporation | 885.1 Million USD | -267.826% |
| HilleVax, Inc. | 133.34 Million USD | -2341.504% |
| Silo Pharma, Inc. | 3.92 Million USD | -82912.329% |
| Telomir Pharmaceuticals, Inc. Common Stock | 3.94 Million USD | -82487.122% |
| Pharming Group N.V. | 225.49 Million USD | -1343.793% |
| Tharimmune, Inc. | 9.45 Million USD | -34332.028% |
| Genprex, Inc. | 31.06 Million USD | -10381.535% |
| Apogee Therapeutics, Inc. | 93 Million USD | -3400.558% |
| Neumora Therapeutics, Inc. Common Stock | 187.52 Million USD | -1636.092% |
| Pyxis Oncology, Inc. | 82.19 Million USD | -3860.806% |
| XTL Biopharmaceuticals Ltd. | 765 Thousand USD | -425471.765% |
| Virios Therapeutics, Inc. | 5.44 Million USD | -59670.009% |
| OKYO Pharma Limited | 8243.57 USD | -39492789.61% |
| Savara Inc. | 15.74 Million USD | -20577.193% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -18549.39% |
| Curis, Inc. | 58.35 Million USD | -5478.998% |
| Carmell Therapeutics Corporation | 5.09 Million USD | -63829.93% |
| Achieve Life Sciences, Inc. | 27.02 Million USD | -11948.05% |
| BeiGene, Ltd. | 3.28 Billion USD | 0.942% |
| Protagonist Therapeutics, Inc. | 153.65 Million USD | -2018.83% |
| Erasca, Inc. | 141.52 Million USD | -2200.388% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -71816.119% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -71816.119% |
| Vincerx Pharma, Inc. | 42.6 Million USD | -7540.696% |
| Fresh Tracks Therapeutics, Inc. | 14.36 Million USD | -22562.008% |
| Acrivon Therapeutics, Inc. Common Stock | 66.7 Million USD | -4780.922% |
| Celldex Therapeutics, Inc. | 43.41 Million USD | -7399.019% |
| Cogent Biosciences, Inc. | 208.13 Million USD | -1464.226% |
| Adicet Bio, Inc. | 152.03 Million USD | -2041.323% |
| Amicus Therapeutics, Inc. | 427.65 Million USD | -661.281% |
| Aditxt, Inc. | 25.95 Million USD | -12445.387% |
| Adagene Inc. | 41.83 Million USD | -7682.736% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -44435.983% |
| Quantum-Si incorporated | 111.65 Million USD | -2815.684% |
| Acurx Pharmaceuticals, Inc. | 14.57 Million USD | -22232.802% |
| Voyager Therapeutics, Inc. | 35.82 Million USD | -8988.337% |
| Compugen Ltd. | 43.97 Million USD | -7304.025% |
| Generation Bio Co. | 144.46 Million USD | -2153.542% |
| Astria Therapeutics, Inc. | 83.03 Million USD | -3821.021% |
| Black Diamond Therapeutics, Inc. | 86.46 Million USD | -3665.468% |
| Invivyd, Inc. | 205.75 Million USD | -1482.282% |
| Relay Therapeutics, Inc. | 72.15 Million USD | -4411.737% |
| Quoin Pharmaceuticals, Ltd. | 9.37 Million USD | -34613.681% |
| Spero Therapeutics, Inc. | 75.25 Million USD | -4226.181% |
| Artelo Biosciences, Inc. | 10.28 Million USD | -31547.944% |
| 2seventy bio, Inc. | 289.88 Million USD | -1023.067% |
| Instil Bio, Inc. | 85.78 Million USD | -3695.097% |
| Capricor Therapeutics, Inc. | 12.8 Million USD | -25318.902% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -286845.301% |
| GeoVax Labs, Inc. | 6.02 Million USD | -53960.619% |
| Citius Pharmaceuticals, Inc. | 36.73 Million USD | -8763.178% |
| Relmada Therapeutics, Inc. | 103.7 Million USD | -3039.403% |
| ALX Oncology Holdings Inc. | 170.27 Million USD | -1811.946% |
| Vir Biotechnology, Inc. | 767.72 Million USD | -324.064% |
| Evaxion Biotech A/S | 22.27 Million USD | -14518.877% |
| Ocular Therapeutix, Inc. | 135.54 Million USD | -2301.895% |
| Verve Therapeutics, Inc. | 234.88 Million USD | -1286.068% |
| Tyra Biosciences, Inc. | 79.94 Million USD | -3972.33% |
| Cingulate Inc. | 22.75 Million USD | -14204.657% |
| Galmed Pharmaceuticals Ltd. | -7.49 Million USD | 43554.672% |
| Unity Biotechnology, Inc. | 44.66 Million USD | -7188.656% |
| Connect Biopharma Holdings Limited | 62.07 Million USD | -5144.747% |
| Clearmind Medicine Inc. | 8.74 Million USD | -37143.95% |
| Bolt Biotherapeutics, Inc. | 84.07 Million USD | -3772.424% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -110900.363% |
| Viking Therapeutics, Inc. | 100.82 Million USD | -3128.921% |
| Madrigal Pharmaceuticals, Inc. | 380.49 Million USD | -755.626% |
| ImmunityBio, Inc. | 362.87 Million USD | -797.182% |
| Korro Bio, Inc. | 84.53 Million USD | -3751.26% |
| Kineta, Inc. | 21.15 Million USD | -15288.656% |
| BioVie Inc. | 31.95 Million USD | -10089.68% |
| Codexis, Inc. | 66.51 Million USD | -4794.35% |
| Celularity Inc. | 215.05 Million USD | -1413.835% |
| Aileron Therapeutics, Inc. | 16.27 Million USD | -19902.605% |
| Crinetics Pharmaceuticals, Inc. | 226.62 Million USD | -1336.594% |
| Virax Biolabs Group Limited | 6.54 Million USD | -49626.48% |
| Cibus, Inc. | 320.3 Million USD | -916.414% |
| IN8bio, Inc. | 30.33 Million USD | -10631.529% |
| Adverum Biotechnologies, Inc. | 127.59 Million USD | -2451.609% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -508591.25% |
| Ionis Pharmaceuticals, Inc. | 779.58 Million USD | -317.609% |
| Eyenovia, Inc. | 25.4 Million USD | -12714.165% |
| Puma Biotechnology, Inc. | 140.31 Million USD | -2220.225% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -58433.333% |
| Elevation Oncology, Inc. | 45.44 Million USD | -7063.877% |
| Xilio Therapeutics, Inc. | 79.13 Million USD | -4014.117% |
| Cardiff Oncology, Inc. | 45.9 Million USD | -6992.863% |
| Enanta Pharmaceuticals, Inc. | 216.41 Million USD | -1404.371% |
| Regulus Therapeutics Inc. | 9.95 Million USD | -32596.836% |
| Moolec Science SA | 52.75 Million USD | -6071.728% |
| Acumen Pharmaceuticals, Inc. | 61.13 Million USD | -5225.042% |
| LAVA Therapeutics N.V. | 46.54 Million USD | -6895.324% |
| Atea Pharmaceuticals, Inc. | 94.07 Million USD | -3360.779% |
| Compass Therapeutics, Inc. | 48.47 Million USD | -6616.366% |
| Greenwich LifeSciences, Inc. | 9.32 Million USD | -34802.131% |
| TFF Pharmaceuticals, Inc. | 22.62 Million USD | -14287.252% |
| Humacyte, Inc. | 23.49 Million USD | -13755.488% |
| PMV Pharmaceuticals, Inc. | 80.13 Million USD | -3962.826% |
| Avenue Therapeutics, Inc. | 14.54 Million USD | -22290.812% |
| Genelux Corporation | 24.33 Million USD | -13278.36% |
| Trevi Therapeutics, Inc. | 33.92 Million USD | -9497.099% |
| Notable Labs, Ltd. | 14.77 Million USD | -21942.139% |
| Immunovant, Inc. | 282.7 Million USD | -1051.581% |
| Quantum-Si incorporated | 111.65 Million USD | -2815.684% |
| DiaMedica Therapeutics Inc. | 21.26 Million USD | -15208.337% |
| Vera Therapeutics, Inc. | 102.01 Million USD | -3091.413% |
| Acasti Pharma Inc. | 11.3 Million USD | -28708.282% |
| MiNK Therapeutics, Inc. | 22.92 Million USD | -14103.608% |
| Soleno Therapeutics, Inc. | 41.38 Million USD | -7766.866% |
| PepGen Inc. | 84.76 Million USD | -3740.719% |
| Nuvectis Pharma, Inc. | 22.89 Million USD | -14118.561% |
| BriaCell Therapeutics Corp. | 32.72 Million USD | -9848.269% |
| Immuneering Corporation | 58.41 Million USD | -5473.469% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -63858.213% |
| Belite Bio, Inc | 31.66 Million USD | -10180.485% |
| XOMA Corporation | 46.46 Million USD | -6906.917% |
| ARS Pharmaceuticals, Inc. | 67.55 Million USD | -4719.577% |
| Bionomics Limited | 17.89 Billion USD | 81.804% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 9224.507% |
| uniQure N.V. | 285.08 Million USD | -1041.98% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -44435.983% |
| Poseida Therapeutics, Inc. | 194.2 Million USD | -1576.368% |
| Forte Biosciences, Inc. | 32.47 Million USD | -9924.399% |
| Anebulo Pharmaceuticals, Inc. | 8.3 Million USD | -39083.055% |
| Enlivex Therapeutics Ltd. | 29.39 Million USD | -10975.435% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -58433.333% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -22810.795% |
| FibroBiologics, Inc. Common Stock | 8.88 Million USD | -36525.312% |
| Altimmune, Inc. | 30.55 Million USD | -10554.614% |
| LENZ Therapeutics, Inc. | 70.7 Million USD | -4504.648% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 9224.507% |
| Peak Bio, Inc. | 1249.13 USD | -260631219.398% |
| Zevra Therapeutics, Inc. | 74.12 Million USD | -4292.369% |
| Benitec Biopharma Inc. | 22.38 Million USD | -14445.724% |
| Spyre Therapeutics, Inc. | 243.18 Million USD | -1238.722% |
| NKGen Biotech, Inc. Common Stock | 28.54 Million USD | -11306.033% |
| Zura Bio Limited | 62.63 Million USD | -5097.522% |
| PolyPid Ltd. | 21.04 Million USD | -15369.822% |
| NKGen Biotech, Inc. Warrants | 28.54 Million USD | -11306.033% |
| argenx SE | 1.53 Billion USD | -112.296% |
| Immunome, Inc. | 122.82 Million USD | -2550.728% |
| Verona Pharma plc | 67.15 Million USD | -4748.194% |
| enGene Holdings Inc. Warrants | 25.88 Million USD | -12477.261% |
| Shattuck Labs, Inc. | 93.61 Million USD | -3377.711% |
| CervoMed Inc. | 14.95 Million USD | -21665.441% |
| Plus Therapeutics, Inc. | 8.54 Million USD | -38004.213% |
| Dianthus Therapeutics, Inc. | 51 Million USD | -6283.576% |
| Moolec Science SA | 52.75 Million USD | -6071.728% |
| Enveric Biosciences, Inc. | 16.44 Million USD | -19692.904% |
| Design Therapeutics, Inc. | 78.19 Million USD | -4063.734% |
| Leap Therapeutics, Inc. | 87.04 Million USD | -3640.334% |
| Seelos Therapeutics, Inc. | 12.58 Million USD | -25769.082% |
| Achilles Therapeutics plc | 75.25 Million USD | -4226.123% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -110900.363% |
| CG Oncology, Inc. Common stock | 55.65 Million USD | -5749.863% |
| Fractyl Health, Inc. Common Stock | 50.87 Million USD | -6298.758% |
| Rani Therapeutics Holdings, Inc. | 66.09 Million USD | -4825.376% |
| MoonLake Immunotherapeutics | 54.12 Million USD | -5915.221% |
| Tourmaline Bio, Inc. | 45.4 Million USD | -7069.557% |
| Beam Therapeutics Inc. | 554.19 Million USD | -487.452% |
| Mirum Pharmaceuticals, Inc. | 248.48 Million USD | -1210.168% |
| AEON Biopharma, Inc. | 48.42 Million USD | -6622.468% |
| Aadi Bioscience, Inc. | 93.47 Million USD | -3382.77% |
| Enliven Therapeutics, Inc. | 83.52 Million USD | -3797.597% |
| Kiora Pharmaceuticals, Inc. | 12.58 Million USD | -25765.186% |
| NeurAxis, Inc. | 8.82 Million USD | -36806.82% |
| Iovance Biotherapeutics, Inc. | 450.99 Million USD | -621.879% |
| Lumos Pharma, Inc. | 38.66 Million USD | -8320.08% |
| Opiant Pharmaceuticals, Inc. | 26.5 Million USD | -12184.242% |
| Palisade Bio, Inc. | 13.32 Million USD | -24341.622% |
| Nutriband Inc. | 5.73 Million USD | -56677.231% |
| Taysha Gene Therapies, Inc. | 87.89 Million USD | -3604.203% |
| Neurogene Inc. | 55.58 Million USD | -5757.23% |
| Kintara Therapeutics, Inc. | 8.45 Million USD | -38423.536% |
| CARGO Therapeutics, Inc. Common Stock | 96.71 Million USD | -3266.378% |
| Athira Pharma, Inc. | 125.46 Million USD | -2494.826% |
| HCW Biologics Inc. | 21.02 Million USD | -15382.682% |
| XOMA Corporation | 46.46 Million USD | -6906.917% |
| Nektar Therapeutics | 190.9 Million USD | -1605.381% |
| Arvinas, Inc. | 480 Million USD | -578.255% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -143069.171% |
| Merus N.V. | 200.49 Million USD | -1523.801% |
| Omega Therapeutics, Inc. | 103.35 Million USD | -3049.943% |
| Quince Therapeutics, Inc. | 34.62 Million USD | -9303.882% |
| Rezolute, Inc. | 70.38 Million USD | -4525.32% |
| Clene Inc. | 41.07 Million USD | -7826.433% |
| Indaptus Therapeutics, Inc. | 16.37 Million USD | -19777.456% |
| BeyondSpring Inc. | 24.86 Million USD | -12993.199% |
| Synlogic, Inc. | 58.53 Million USD | -5462.127% |
| Allarity Therapeutics, Inc. | 17.89 Million USD | -18095.976% |
| Phio Pharmaceuticals Corp. | 4.49 Million USD | -72376.046% |
| Peak Bio, Inc. | 1249.13 USD | -260631219.398% |
| Werewolf Therapeutics, Inc. | 60.44 Million USD | -5286.004% |
| Krystal Biotech, Inc. | 160.42 Million USD | -1929.362% |
| Karyopharm Therapeutics Inc. | 270.63 Million USD | -1102.975% |
| SpringWorks Therapeutics, Inc. | 348.03 Million USD | -835.422% |
| Lipella Pharmaceuticals Inc. | 2.15 Million USD | -150851.578% |
| MannKind Corporation | 125.59 Million USD | -2492.119% |
| Ikena Oncology, Inc. | 84.57 Million USD | -3749.302% |
| Cyclerion Therapeutics, Inc. | 9.64 Million USD | -33647.528% |
| Gyre Therapeutics, Inc. | 89.6 Million USD | -3533.468% |
| Gossamer Bio, Inc. | 183.75 Million USD | -1671.681% |
| CohBar, Inc. | 12.38 Million USD | -26179.835% |
| Cognition Therapeutics, Inc. | 50.72 Million USD | -6318.311% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -11703.437% |
| Legend Biotech Corporation | 583.14 Million USD | -458.287% |
| Mural Oncology plc | 192.07 Million USD | -1595.011% |
| Disc Medicine, Inc. | 91.12 Million USD | -3472.701% |
| Champions Oncology, Inc. | 28.11 Million USD | -11481.729% |
| REGENXBIO Inc. | 321.15 Million USD | -913.717% |
| Ensysce Biosciences, Inc. | 5.36 Million USD | -60625.273% |
| Anavex Life Sciences Corp. | 55.75 Million USD | -5739.056% |
| Cellectar Biosciences, Inc. | 38.96 Million USD | -8256.187% |
| Edgewise Therapeutics, Inc. | 114.35 Million USD | -2746.895% |
| Vaxart, Inc. | 90.72 Million USD | -3488.413% |
| PharmaCyte Biotech, Inc. | 8.52 Million USD | -38111.513% |
| Aldeyra Therapeutics, Inc. | 42.79 Million USD | -7507.65% |
| Cellectis S.A. | 97.32 Million USD | -3245.277% |
| Longeveron Inc. | 21.25 Million USD | -15220.584% |
| Repare Therapeutics Inc. | 167.35 Million USD | -1845.317% |
| Sarepta Therapeutics, Inc. | 1.36 Billion USD | -139.24% |
| Inozyme Pharma, Inc. | 75.64 Million USD | -4203.819% |
| Revolution Medicines, Inc. | 498.76 Million USD | -552.737% |
| Nymox Pharmaceutical Corporation | 6.65 Million USD | -48842.032% |
| Third Harmonic Bio, Inc. | 43.95 Million USD | -7306.889% |
| ArriVent BioPharma, Inc. Common Stock | 74.59 Million USD | -4264.692% |
| AN2 Therapeutics, Inc. | 69.63 Million USD | -4575.27% |
| Anixa Biosciences, Inc. | 11.06 Million USD | -29336.022% |
| Vertex Pharmaceuticals Incorporated | 4.77 Billion USD | 31.819% |
| Denali Therapeutics Inc. | 527.23 Million USD | -517.496% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -37508.298% |
| Veru Inc. | 101.34 Million USD | -3112.317% |
| Corvus Pharmaceuticals, Inc. | 23.4 Million USD | -13808.762% |
| Cingulate Inc. | 22.75 Million USD | -14204.657% |
| Passage Bio, Inc. | 108.38 Million USD | -2903.648% |
| Context Therapeutics Inc. | 25.07 Million USD | -12884.78% |
| Exicure, Inc. | 14.07 Million USD | -23028.9% |
| Day One Biopharmaceuticals, Inc. | 206.06 Million USD | -1479.909% |
| Oramed Pharmaceuticals Inc. | 43.3 Million USD | -7418.588% |
| Scinai Immunotherapeutics Ltd. | 9.17 Million USD | -35374.786% |
| Nuvalent, Inc. | 149.49 Million USD | -2077.791% |
| ABVC BioPharma, Inc. | 8.06 Million USD | -40257.798% |
| Carisma Therapeutics, Inc. | 103.65 Million USD | -3040.978% |
| Unicycive Therapeutics, Inc. | 21.44 Million USD | -15078.442% |
| OmniAb, Inc. | 83.89 Million USD | -3780.594% |
| Anew Medical, Inc. | 1.3 Million USD | -250170.709% |
| Fennec Pharmaceuticals Inc. | 32.76 Million USD | -9836.589% |
| Lipocine Inc. | 15.08 Million USD | -21488.82% |
| Lexeo Therapeutics, Inc. Common Stock | 68.51 Million USD | -4651.834% |
| Nautilus Biotechnology, Inc. | 76.15 Million USD | -4175.165% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -7975.604% |
| G1 Therapeutics, Inc. | 114.84 Million USD | -2734.848% |
| Bellerophon Therapeutics, Inc. | 22.38 Million USD | -14444.425% |
| Sage Therapeutics, Inc. | 664.14 Million USD | -390.198% |
| Ocugen, Inc. | 71.56 Million USD | -4449.058% |
| Mind Medicine (MindMed) Inc. | 93.86 Million USD | -3368.374% |
| Q32 Bio Inc. | 92.68 Million USD | -3412.758% |
| Brainstorm Cell Therapeutics Inc. | 21.17 Million USD | -15275.574% |
| Alumis Inc. Common Stock | 158.17 Million USD | -1958.255% |
| Equillium, Inc. | 50.6 Million USD | -6333.277% |
| Kyverna Therapeutics, Inc. | 62.4 Million USD | -5116.845% |
| Coya Therapeutics, Inc. | 13.9 Million USD | -23312.399% |
| CNS Pharmaceuticals, Inc. | 18.86 Million USD | -17157.383% |
| Dominari Holdings Inc. | 23.83 Million USD | -13559.006% |
| Edesa Biotech, Inc. | 9.22 Million USD | -35199.896% |
| vTv Therapeutics Inc. | 11.9 Million USD | -27242.101% |
| Bio-Techne Corporation | 563.03 Million USD | -478.224% |
| Agios Pharmaceuticals, Inc. | 408.8 Million USD | -696.374% |
| Harmony Biosciences Holdings, Inc. | 268.75 Million USD | -1111.368% |
| Prelude Therapeutics Incorporated | 132.27 Million USD | -2361.217% |
| Candel Therapeutics, Inc. | 14.41 Million USD | -22491.243% |
| iTeos Therapeutics, Inc. | 163.69 Million USD | -1888.823% |
| Nkarta, Inc. | 131.65 Million USD | -2372.939% |
| BioCardia, Inc. | 12.12 Million USD | -26759.368% |
| Iterum Therapeutics plc | 47.46 Million USD | -6758.566% |